| (USD) | Jun 2023 | Q/Q |
|---|---|---|
| Revenue | 90MM | +2% |
| Gross Profit | 22.5MM | - |
| Cost Of Revenue | 67.5MM | -0% |
| Operating Income | -9MM | +47% |
| Operating Expenses | 31.6MM | +17% |
| Net Income | -9.9MM | -38% |
| R&D | 1.8MM | +39% |
| G&A | 17.6MM | +6% |
| Marketing | 2.7MM | +11% |
| Amortization | 1.6MM | -0% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Tabula Rasa HealthCare, Inc.® ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based organizations, today announced that its stockholders approved the previously announced acquisition by Nautic Partners ("Nautic"), following which TRHC is expected to combine with ExactCare Pharmacy, a portfolio company of Nautic. The proposal to adopt the merger agreement was approved at a virtual special meeting of the Company's stockhol
Key Insights Given the large stake in the stock by institutions, Tabula Rasa HealthCare's stock price might be...
The company announced it was entering into a merger agreement to be acquired by Nautic Partners and will combine with ExactCare Pharmacy, a portfolio company of Nautic.
The proposed deal would result in the merger of Tabula Rasa and ExactCare Pharmacy, a portfolio company of Rhode Island-based Nautic Partners.
Although the revenue and EPS for Tabula Rasa Healthcare (TRHC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 135.71% and 1.37%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Tabula Rasa HealthCare, Inc.® (Nasdaq:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023.
Tabula Rasa HealthCare, Inc.® ("TRHC," "Tabula Rasa" or the "Company") (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today announced it has entered into a definitive agreement (the "Agreement") to be acquired by Nautic Partners ("Nautic") for $10.50 in cash per share and will combine with ExactCare Pharmacy ("ExactCare"), a portfolio company of Nautic. The all-cash transaction values Tabula Rasa at approximately $570 m
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2023 financial results Tuesday, August 8, 2023 at 8:30 a.m. EDT. The Company's financial results for the second quarter 2023 ended June 30, 2023, will be released after the close of the market Monday, August 7, 2023.
Tabula Rasa Healthcare (TRHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.